Beyond Weight Loss: Practical Considerations for use of Glucagon like Peptide-1 (GLP-1) and Incretin Therapy in Inflammatory Skin Disease. Canadian Dermatology Today, Toronto, Canada, v. 7, n. 3, p. 11–16, 2026. DOI: 10.58931/cdt.2026.73168. Disponível em: https://canadiandermatologytoday.com/article/view/7-3-Shi_et_al. Acesso em: 28 sep. 2026.